Olema Pharmaceuticals CEO Sean Bohen's 2023 pay falls 47% to $3.2M
Olema Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Olema Pharmaceuticals reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, four executives at Olema Pharmaceuticals received on average a compensation package of $1.8M, a 48% decrease compared to previous year.
Average pay of disclosed executives at Olema Pharmaceuticals
Sean Bohen, Chief Executive Officer, received $3.2M in total, which decreased by 47% compared to 2022. 64% of Bohen's compensation, or $2M, was in option awards. Bohen also received $489K in non-equity incentive plan, $647K in salary, as well as $14K in other compensation.
Shane Kovacs, Chief Operating and Financial Officer, received a compensation package of $1.5M, which decreased by 32% compared to previous year. 47% of the compensation package, or $728K, was in option awards.
Cyrus Harmon, Chief Executive Officer, earned $1.3M in 2023.
Naseem Zojwalla, Chief Medical Officer, received $1.3M in 2023, which decreases by 42% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 26, 2024.